Rita Rebelo holds an Integrated MSc in Pharmaceuticals Sciences from the Faculty of Pharmacy of the University of Porto (2018). In 2019, she joined the Cancer Drug Resistance group of  i3S/IPATIMUP, where she has been developing her research work. Rita has published in Molecules, 2021 (Q1; IF:4.411), Pharmaceuticals, 2021 (Q1; IF:5.680), and Archives of Toxicology, 2019 (Q1, IF: 5.059).

Currently, she is conducting research work for her MSc dissertation at the Cancer Drug Resistance Group, under the supervision of Prof. Dr. M. Helena Vasconcelos and co-supervision of Dr. Cristina Xavier.